Literature DB >> 9474533

On the degree of solute mixing in liver models of drug elimination.

M Weiss1.   

Abstract

One of the fundamental differences between various liver models regards the underlying assumptions on the intrahepatic mixing process. A model-independent method for the evaluation of the departure from the perfectly mixed system is proposed which is based on an application of the relative entropy concept to hepatic transit time distributions of intravascular markers. This approach provides a measure of the distance between two probability distributions. Available data measured in isolated perfused livers indicate that sinusoidal solute mixing is nearly optimal. The suggestion of maximum mixedness in the liver may explain the discrepancy between the apparent validity of the venous equilibrium model and the physiological irrelevance of the underlying well-stirred assumption. In terms of the dispersion model the results are in accordance with the model equation obtained for mixed boundary conditions.

Mesh:

Substances:

Year:  1997        PMID: 9474533     DOI: 10.1023/a:1025727926220

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  27 in total

1.  Pharmacokinetic parameter estimations by minimum relative entropy method.

Authors:  T Amisaki; S Eguchi
Journal:  J Pharmacokinet Biopharm       Date:  1995-10

2.  A note on the interpretation of tracer dispersion in the liver.

Authors:  M Weiss
Journal:  J Theor Biol       Date:  1997-01-07       Impact factor: 2.691

3.  Two-compartment dispersion model for analysis of organ perfusion system of drugs by fast inverse Laplace transform (FILT).

Authors:  Y Yano; K Yamaoka; Y Aoyama; H Tanaka
Journal:  J Pharmacokinet Biopharm       Date:  1989-04

4.  On the relation between extended forms of the sinusoidal perfusion and of the convection-dispersion models of hepatic elimination.

Authors:  L Bass; M S Roberts; P J Robinson
Journal:  J Theor Biol       Date:  1987-06-21       Impact factor: 2.691

5.  Models of hepatic drug clearance: discrimination between the 'well stirred' and 'parallel-tube' models.

Authors:  A B Ahmad; P N Bennett; M Rowland
Journal:  J Pharm Pharmacol       Date:  1983-04       Impact factor: 3.765

6.  Physiologic models of hepatic drug clearance: influence of altered protein binding on the elimination of diclofenac in the isolated perfused rat liver.

Authors:  Z Hussein; A M Evans; M Rowland
Journal:  J Pharm Sci       Date:  1993-09       Impact factor: 3.534

7.  Hepatic elimination--dispersion model.

Authors:  M S Roberts; M Rowland
Journal:  J Pharm Sci       Date:  1985-05       Impact factor: 3.534

8.  Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.

Authors:  K S Pang; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1977-12

9.  Application of the axial dispersion model of hepatic drug elimination to the kinetics of diazepam in the isolated perfused rat liver.

Authors:  J M Díaz-García; A M Evans; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1992-04

10.  Models of hepatic elimination: implications from studies of the simultaneous elimination of taurocholate and diazepam by isolated rat liver under varying conditions of binding.

Authors:  M S Ching; D J Morgan; R A Smallwood
Journal:  J Pharmacol Exp Ther       Date:  1989-09       Impact factor: 4.030

View more
  4 in total

1.  Cellular pharmacokinetics: effects of cytoplasmic diffusion and binding on organ transit time distribution.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1999-06

2.  Sensitivity of empirical metrics of rate of absorption in bioequivalence studies.

Authors:  A Ring; L Tothfalusi; L Endrenyi; M Weiss
Journal:  Pharm Res       Date:  2000-05       Impact factor: 4.200

3.  Fractal structure of the liver: effect on drug elimination.

Authors:  Michael Weiss
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-12-05       Impact factor: 2.745

4.  Tissue-level modeling of xenobiotic metabolism in liver: An emerging tool for enabling clinical translational research.

Authors:  Marianthi G Lerapetritou; Panos G Georgopoulos; Charles M Roth; Loannis P Androulakis
Journal:  Clin Transl Sci       Date:  2009-06       Impact factor: 4.689

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.